- Home
- BOSC vs SONN Comparison
BOSC vs SONN Comparison
Compare BOSC & SONN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOSC
- SONN
- Stock Information
- Founded
- BOSC 1990
- SONN N/A
- Country
- BOSC Israel
- SONN United States
- Employees
- BOSC N/A
- SONN N/A
- Industry
- BOSC Computer Communications Equipment
- SONN Biotechnology: Pharmaceutical Preparations
- Sector
- BOSC Telecommunications
- SONN Health Care
- Exchange
- BOSC Nasdaq
- SONN Nasdaq
- Market Cap
- BOSC 29.6M
- SONN 32.4M
- IPO Year
- BOSC 1996
- SONN N/A
- Fundamental
- Price
- BOSC $4.40
- SONN $4.52
- Analyst Decision
- BOSC
- SONN Strong Buy
- Analyst Count
- BOSC 0
- SONN 1
- Target Price
- BOSC N/A
- SONN $20.00
- AVG Volume (30 Days)
- BOSC 237.0K
- SONN 776.4K
- Earning Date
- BOSC 11-25-2025
- SONN 12-16-2025
- Dividend Yield
- BOSC N/A
- SONN N/A
- EPS Growth
- BOSC 55.92
- SONN N/A
- EPS
- BOSC 0.52
- SONN N/A
- Revenue
- BOSC $46,768,000.00
- SONN $1,000,000.00
- Revenue This Year
- BOSC N/A
- SONN $5,376.22
- Revenue Next Year
- BOSC N/A
- SONN N/A
- P/E Ratio
- BOSC $8.47
- SONN N/A
- Revenue Growth
- BOSC 15.66
- SONN 1689.52
- 52 Week Low
- BOSC $3.14
- SONN $1.08
- 52 Week High
- BOSC $6.72
- SONN $19.30
- Technical
- Relative Strength Index (RSI)
- BOSC 34.01
- SONN 47.92
- Support Level
- BOSC $4.32
- SONN $4.05
- Resistance Level
- BOSC $5.31
- SONN $5.14
- Average True Range (ATR)
- BOSC 0.33
- SONN 0.94
- MACD
- BOSC -0.16
- SONN -0.02
- Stochastic Oscillator
- BOSC 3.63
- SONN 48.41
About BOSC B.O.S. Better Online Solutions
BOS Better Online Solutions Ltd is a provider of Intelligent Robotics and Supply Chain solutions for enterprises. The company manages its business in three reportable divisions: the Intelligent Robotics segment, the RFID Division segment, and the Supply Chain Solutions segment. The majority of revenue derives from Supply Chain Solutions which distributes electro-mechanical components, mainly to customers in the aerospace, defense, and other industries, and is a supply chain service provider for aviation customers that seek a comprehensive solution to their components-supply needs. Geographically company derives the majority of its revenue from Israel.
About SONN Sonnet BioTherapeutics Holdings Inc.
Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The Company views its operations and manages its business in one segment. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.